DIAMEDICA THERAPEUTICS INC (DMAC) Institutional Ownership and Insiders Activity

DIAMEDICA THERAPEUTICS INC (DMAC) is widely held by institutional investors, with 85 firms reporting positions valued at approximately $93.20M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Cooperman Leon G is the largest disclosed holder, reporting approximately $24.29M in DMAC holdings in its latest filing.

Recent insider activity includes 1 tracked Form 4 transaction over the last three months, reflecting ongoing executive and director trading activity.